Compounds > nepafenac
Page last updated: 2024-09-04

nepafenac and Pain

nepafenac has been researched along with Pain in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Aggarwal, P; Bardoloi, N; Burgute, PS; Deb, AK; Dholkawala, R; Gokhale, T; Sarkar, S1
Aretha, D; Georgakopoulos, CD; Makri, OE; Plotas, P; Tsapardoni, FN1
Georgakopoulos, CD; Kagkelaris, K; Makri, OE; Plotas, P; Tsapardoni, F1
Agarwal, M; Bekendam, PD; Narváez, J1

Trials

3 trial(s) available for nepafenac and Pain

ArticleYear
Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Humans; Inflammation; Middle Aged; Ophthalmic Solutions; Pain; Phacoemulsification; Phenylacetates; Prospective Studies; Single-Blind Method

2022
Analgesic Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections: A Randomized Crossover Study.
    Current eye research, 2018, Volume: 43, Issue:8

    Topics: Administration, Topical; Aged; Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Intravitreal Injections; Male; Ophthalmic Solutions; Pain; Pain Measurement; Phenylacetates; Prospective Studies; Treatment Outcome

2018
Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2019, Volume: 35, Issue:3

    Topics: Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmic Solutions; Pain; Pain Measurement; Phenylacetates; Prospective Studies; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factors

2019

Other Studies

1 other study(ies) available for nepafenac and Pain

ArticleYear
Case of corneal melting associated with the use of topical nepafenac.
    Cornea, 2007, Volume: 26, Issue:8

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Ulcer; Decompression, Surgical; Female; Humans; Middle Aged; Pain; Phenylacetates

2007